Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell Carcinoma
Status:
Recruiting
Trial end date:
2026-02-18
Target enrollment:
Participant gender:
Summary
This study is a prospective, multicenter, open-label, single-arm phase II clinical trial. A
single-arm experimental group of toripalimab, etoposide, and cisplatin/carboplatin was
designed to evaluate its efficacy and safety in small cell carcinoma of the urinary system.